Demonstrates effective myeloablative conditioning before HSCT in children with high-risk myeloid malignancies, suggesting a suitable treatment option.
Busulfan, fludarabine and melphalan conditioning was well tolerated and effective, representing a suitable treatment option for heavily pretreated children with high-risk myeloid malignancies prior to HSCT.
No takes yet. Share an insight, caveat, or question.
Dhamija et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: